Outlook Therapeutics Reports Q2 2026 Results

What Happened Outlook Therapeutics, Inc. announced its financial results for the second fiscal quarter ended June 30, 2026 in a press release dated August 14, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K and said it will post a business update slide presentation from the earnings call on its website.

Key Details

• Filing date: August 14, 2026 (Form 8-K reporting Item 2.02 and Item 9.01).
• Reporting period: second fiscal quarter ended June 30, 2026.
• Press release: furnished as Exhibit 99.1 to the 8-K (dated August 14, 2026).
• Investor materials: company to post earnings call slide presentation on its website alongside the release.

Why It Matters An 8-K reporting quarterly results provides updated earnings and financial condition information investors use to evaluate performance, liquidity, and near-term prospects. The furnished press release and accompanying slide deck are the primary sources for those updated figures and management commentary; shareholders and analysts should review them for revenue, expenses, cash position, guidance (if provided), and any changes to operations or strategy.